<p>Number of local solicited adverse events during week 1 and 2 for each dose group (n = 12 per group).</p
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
<p>N, number of patients; n, number of events; %, percentage based on N = 275.</p
Adverse events by preferred term with an incidence of ≥5% in any treatment group (Safety analysis se...
<p>Number of systemic solicited adverse events during week 1 and 2 for each dose group (n = 12 per g...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
<p>N, number of participants with at least one event.</p><p>Adverse events by system organ class and...
Adverse events (according to low-level term) reported in at least 10 patients during follow-up.</p
<p>Number and percentages of participants with solicited adverse events after any vaccination, and u...
<p>Solicited reactogenicity was collected for 7 days after each vaccination for 21 days total after ...
<p>Numbers of Subjects Who Changed From Initial High Risk to Low Risk and From Initial Low Risk to H...
<p>Frequency of Serious Adverse Drug Reactions by HIV status and months of treatment.</p
#<p> This refers to the number of patients switching treatment due to specific toxicity specified on...
<p>N: Number of subjects inoculated; n: Number of subjects with adverse events; E: Number of adverse...
<p>Number of participants with at least one adverse event, and severity of the worst event per parti...
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
<p>N, number of patients; n, number of events; %, percentage based on N = 275.</p
Adverse events by preferred term with an incidence of ≥5% in any treatment group (Safety analysis se...
<p>Number of systemic solicited adverse events during week 1 and 2 for each dose group (n = 12 per g...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
<p>N, number of participants with at least one event.</p><p>Adverse events by system organ class and...
Adverse events (according to low-level term) reported in at least 10 patients during follow-up.</p
<p>Number and percentages of participants with solicited adverse events after any vaccination, and u...
<p>Solicited reactogenicity was collected for 7 days after each vaccination for 21 days total after ...
<p>Numbers of Subjects Who Changed From Initial High Risk to Low Risk and From Initial Low Risk to H...
<p>Frequency of Serious Adverse Drug Reactions by HIV status and months of treatment.</p
#<p> This refers to the number of patients switching treatment due to specific toxicity specified on...
<p>N: Number of subjects inoculated; n: Number of subjects with adverse events; E: Number of adverse...
<p>Number of participants with at least one adverse event, and severity of the worst event per parti...
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
<p>N, number of patients; n, number of events; %, percentage based on N = 275.</p
Adverse events by preferred term with an incidence of ≥5% in any treatment group (Safety analysis se...